Towards clinical proteomics on a next generation sequencing platform
Towards clinical proteomics on a next generation sequencing platform
R&D project to assess ability of Illumina sequencing to quantify oligonucleotide ligands.
This is the first proof of principle that NGS combined with aptamer technology can be applied to identification and quantification of proteins.